baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Rubis S.A./ FR0013269123 /

31/05/2024 07:57:33	Chg. +0.5000	Volume	Bid21:59:36	Ask21:59:36	Market Capitalization	Dividend Y.	P/E Ratio
32.4400EUR	+1.57%	- Turnover: -	33.0200Bid Size: 122	33.2000Ask Size: 122	3.37 bill.EUR	-	9.53

GlobeNewswire 08/11/2023 Hemper and 40 Tons Launch Rolling Tray Collab to Raise Awareness for Incarcerated Individuals

Newsfile Corp 04/10/2023 The New Immersive Exhibition, A Portal for Healing, Opening at theART-Dept. In West Hollywood Octobe...

GlobeNewswire 21/05/2021 Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines...

GlobeNewswire 17/05/2021 Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College ...

GlobeNewswire 06/05/2021 Athenex Provides First Quarter 2021 Corporate and Financial Update

GlobeNewswire 04/05/2021 Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineere...

GlobeNewswire 27/04/2021 Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021

GlobeNewswire 01/03/2021 Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update

GlobeNewswire 01/03/2021 Athenex Receives FDA Complete Response Letter for Oral Paclitaxel Plus Encequidar for the Treatment ...

GlobeNewswire 22/02/2021 Athenex to Provide a Corporate and Financial Update for the Fourth Quarter and Full Year 2020 on Mar...

GlobeNewswire 18/02/2021 Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin

GlobeNewswire 11/02/2021 Athenex Announces New England Journal of Medicine Publication of Phase III Data on the Efficacy and ...

GlobeNewswire 25/01/2021 CEO Dr. Johnson Lau Recuperating from COVID at Home

GlobeNewswire 08/01/2021 CEO Dr. Johnson Lau Contracts COVID-19

GlobeNewswire 05/01/2021 Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 15/12/2020 Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on ...

GlobeNewswire 09/12/2020 Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel a...

GlobeNewswire 02/12/2020 Athenex Pharmaceutical Division and Ingenus Pharmaceuticals Announce Availability of Liquid, Ready t...

GlobeNewswire 17/11/2020 Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Bre...

GlobeNewswire 05/11/2020 Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporat...

GlobeNewswire 22/10/2020 Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020

GlobeNewswire 12/10/2020 Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell...

GlobeNewswire 29/04/2019 The Kenyan Petroleum Industry 2019: State & Size of the Industry, Influencing Factors, and Competiti...

GlobeNewswire 19/01/2018 RUBIS: Issue of new shares (Equity Line)

GlobeNewswire 12/01/2018 RUBIS : BITUMEN BUSINESS GETS MORE INTERNATIONAL

Rubis S.A./ FR0013269123 /

If you wish to receive reply to your feedback, please provide your email address.